CONNECT WITH US
HealthTech

HealthTech

CancerIQ Expands Native Epic Integrations to Automate Cancer Screening and Survivorship Across 275 Clinics

HIT Consultant logo

Published on

Add as a preferred source on Google
CancerIQ Expands Native Epic Integrations to Automate Cancer Screening and Survivorship Across 275 Clinics

Precision oncology and cancer risk intelligence platform CancerIQ announced a major architectural upgrade to its Epic Systems integrations, introducing a redesigned patient experience via Risk Hub and a consolidated provider application deployed natively inside Epic workflows.

Built natively on the HL7 FHIR R4 interoperability standard, the provider integration enables chart-aware risk assessment that automatically pulls existing clinical variables from Epic—including family cancer histories, personal diagnoses, prior breast biopsies, breast density reports, lab findings, and medication regimens—to eliminate duplicative patient data entry.

Embeds clinical decision-support guidelines directly into Epic to identify patient eligibility across hereditary risk screening, germline and somatic genetic testing, biomarker panels, minimal residual disease (MRD) monitoring, and multi-cancer early detection (MCED) blood tests without requiring clinicians to switch windows or log into external third-party portals.

Deployed across more than 60 health systems and 275 clinic locations (reaching roughly 1 in 10 patients nationwide), the upgraded integrations are accessible via Connection Hub on the Epic Showroom.

The upgraded provider integration uses the HL7 FHIR R4 standard to bi-directionally read from and write to Epic, eliminating redundant data entry and keeping clinicians within their native EHR interface:

Prepopulated Chart Ingestion: Automatically ingests existing chart data—including family cancer histories, personal diagnoses, prior biopsies, breast density markers, medication lists, and past lab/genomic results—to auto-populate risk assessment models before the clinician opens the chart.

Embedded Guideline Engine: Evaluates ingested patient data against evidence-based clinical guidelines to determine eligibility for: Hereditary cancer risk assessment and genetic testing (e.g., BRCA1/2 , Lynch syndrome).

Unified In-EHR Workflows: Clinicians can review and refine pedigrees, order indicated genetic/biomarker tests through standard EHR computerized provider order entry (CPOE), and generate personalized care plans (screening intervals, imaging modalities, and specialty referrals) directly within Epic.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.